Connect with us

Technology

Hyperscale Data Announces “At-the-Market” Offering of Common Stock

Published

on

LAS VEGAS, June 18, 2026 /PRNewswire/ — Hyperscale Data, Inc. (NYSE American: GPUS), an artificial intelligence (“AI”) data center company anchored by Bitcoin (“Hyperscale Data” or the “Company”), announced today that it has established an “at-the-market” equity offering program (the “Offering”) under which it may sell, from time to time, shares of its common stock for aggregate gross proceeds of up to $300 million. The shares of common stock will be offered through Spartan Capital Securities, LLC, which will act in its capacity as sales agent (the “Agent”).

Pursuant to a sales agreement with the Agent, sales of shares of the Company’s common stock may be made in transactions that are deemed to be “at-the-market” offerings, including sales made by means of ordinary brokers’ transactions on the NYSE American or otherwise at market prices prevailing at the time of sale or as agreed to with the Agent.

The Company intends to use a majority of the net proceeds from this offering, if any, to further develop its Michigan and Montana data facilities, to acquire more Bitcoin and to purchase precious metals, including gold, silver and/or copper. The Company also intends to use a smaller amount of the proceeds for working capital and general corporate purposes, which may include the repayment, refinancing, redemption or repurchase of future indebtedness or capital stock. As of the date hereof, the Company cannot predict with certainty all of the particular uses for the net proceeds from this offering, if any. As a result, Hyperscale Data’s management will have broad discretion regarding the timing and application of the net proceeds from this offering.

The shares of common stock described above are being offered pursuant to a shelf registration statement (File No. 333-291595), which became effective on December 11, 2025.  Such shares of common stock may be offered only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. Before making an investment in these securities, potential investors should read the prospectus supplement and the accompanying prospectus for more complete information about the Company and the Offering. Potential investors may obtain these documents for free by visiting EDGAR on the U.S. Securities and Exchange Commission’s website at www.sec.gov. Alternatively, potential investors may contact the Agent, which will arrange to send them these documents:  Spartan Capital Securities, LLC, Attention: Eric Flesche, President, 45 Broadway, 19th Floor, New York, NY 10006, telephone: (212) 293-0123, eflesche@spartancapital.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities, in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.

For more information on Hyperscale Data and its subsidiaries, Hyperscale Data recommends that stockholders, investors and any other interested parties read Hyperscale Data’s public filings and press releases available under the Investor Relations section at hyperscaledata.com or available at www.sec.gov.

About Hyperscale Data, Inc.

Through its wholly owned subsidiary Sentinum, Hyperscale Data owns and operates a data center at which it mines digital assets and offers colocation and hosting services for the emerging AI ecosystems and other industries. Hyperscale Data’s other wholly owned subsidiary, Ault Capital Group, Inc. (“ACG”), is a diversified holding company pursuing growth by acquiring undervalued businesses and disruptive technologies with a global impact.

Hyperscale Data currently expects the divestiture of ACG (the “Divestiture”) to occur in the second quarter of 2027. Upon the occurrence of the Divestiture, the Company would be an owner and operator of data centers to support high-performance computing services, as well as a holder of the digital assets. Until the Divestiture occurs, the Company will continue to provide, through ACG and its wholly and majority-owned subsidiaries and strategic investments, mission-critical products that support a diverse range of industries, including an AI software platform, social gaming platform, equipment rental services, defense/aerospace, industrial, automotive, medical/biopharma and hotel operations. In addition, ACG is actively engaged in private credit and structured finance through a licensed lending subsidiary. Hyperscale Data’s headquarters are located at 11411 Southern Highlands Parkway, Suite 190, Las Vegas, NV 89141.

On December 23, 2024, the Company issued one million (1,000,000) shares of a newly designated Series F Exchangeable Preferred Stock (the “Series F Preferred Stock”) to all common stockholders and holders of the Series C Preferred Stock on an as-converted basis. The Divestiture will occur through the voluntary exchange of the Series F Preferred Stock for shares of Class A Common Stock and Class B Common Stock of ACG (collectively, the “ACG Shares”). The Company reminds its stockholders that only those holders of the Series F Preferred Stock who agree to surrender such shares, and do not properly withdraw such surrender, in the exchange offer through which the Divestiture will occur, will be entitled to receive the ACG Shares and consequently be shareholders of ACG upon the occurrence of the Divestiture.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “believes,” “plans,” “anticipates,” “projects,” “estimates,” “expects,” “intends,” “strategy,” “future,” “opportunity,” “may,” “will,” “should,” “could,” “potential,” or similar expressions. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties.

Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update any of them publicly in light of new information or future events. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. More information, including potential risk factors, that could affect the Company’s business and financial results are included in the Company’s filings with the U.S. Securities and Exchange Commission, including, but not limited to, the Company’s Forms 10-K, 10-Q and 8-K. All filings are available at www.sec.gov and on the Company’s website at hyperscaledata.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/hyperscale-data-announces-at-the-market-offering-of-common-stock-302804864.html

SOURCE Hyperscale Data Inc.

Continue Reading

Technology

University of Phoenix Highlights Student Success Stories from President’s and Dean’s List Honorees

Published

on

By

Student reflections from President’s and Dean’s List honorees highlight flexibility, career-focused learning and perseverance while balancing work, family and education

PHOENIX, Sept. 9, 2026 /PRNewswire/ — University of Phoenix is spotlighting the experiences of students recognized on its July 2026 President’s and Dean’s Lists, sharing stories that illustrate the dedication, persistence and personal goals behind their academic achievement. As an extension of the July 2026 recognition, the University hosted a giveaway for President’s and Dean’s List honorees and invited eligible students to join the University of Phoenix subreddit and share what had been most valuable about their educational journeys. Responses submitted as part of the giveaway highlighted themes including flexibility, career-focused learning, and pursuing educational goals while balancing work, family and other responsibilities.

Celebrating Student Achievement Across University Programs

In July, the University recognized 32,416 students for academic achievement through its semi-annual President’s and Dean’s Lists. The President’s List honored 9,496 students who earned a 4.0 grade point average (GPA), while 22,920 students were named to the Dean’s Lists for achieving high academic standing in their programs of study.

“Behind every President’s and Dean’s List recognition is a unique story of commitment, perseverance and purpose,” said John Woods, PhD, provost and chief academic officer at University of Phoenix. “The student reflections shared through this initiative highlight the determination our learners bring to their educational journeys and the many ways they balance academic goals alongside career, family and personal responsibilities. We are proud to celebrate not only their academic achievement, but also the experiences that helped shape their success.”

Key Themes Shared by President’s and Dean’s List Students

The giveaway generated 787 eligible student submissions on the University of Phoenix subreddit, with 30 participants selected to receive University of Phoenix swag boxes.

In reviewing the submissions, the University identified several recurring themes, including:

Flexibility to balance education with work and family responsibilitiesCoursework that aligned directly to career goalsEducational milestones such as becoming the first in a family to earn a college degreeContinued learning through advanced degree programs

Students Share Their Educational Journeys

Derell Vanstory, who recently completed a Bachelor of Science in Business and earned Dean’s List recognition, reflected on balancing school, work and family responsibilities while pursuing his degree. This fall, he plans to pursue dual master’s degrees, an MBA and Master of Health Administration, as he works toward a career in healthcare leadership.

“The most valuable part of my journey at the University of Phoenix has been learning how to stay disciplined and resilient,” said Vanstory. “Balancing school, work, and family responsibilities taught me that success isn’t about having an easy path, it’s about continuing to move forward even when things get difficult.”

Reenae Flores, who is pursuing a Bachelor of Science in Business with a concentration in Human Resource Management, described Dean’s List recognition as a meaningful milestone in her educational journey.

“This recognition represents so much more than a GPA,” said Flores. “It represents late nights after work, balancing family life, pushing through challenges, and refusing to give up on a dream that once felt out of reach.”

Flores shared that the flexibility of her educational experience allowed her to continue growing professionally while remaining present for her family.

Alisha Saffold, who recently completed a Bachelor of Science in Health Management, graduated summa cum laude with a 4.0 GPA, and is continuing her education as a Master of Public Health student, highlighted the value of applying classroom learning directly to her professional goals.

“The most valuable part of my University of Phoenix experience has been learning how to apply what I studied directly to my career and my passion for serving others,” said Saffold. “Every course challenged me to think like a healthcare leader and strengthened my commitment to improving access to preventive care, advancing health equity, and making a difference in underserved communities.”

Academic Achievement Among Working Adult Learners

The experiences shared by President’s and Dean’s List honorees reflect those of many University of Phoenix students who pursue education while balancing work, family and other responsibilities. According to University data, 75.4% of students are employed. In the Encoura + Ruffalo Noel Levitz Priorities Survey for Online Learners, 63% of University student respondents indicated they have caregiving responsibilities, while 91% expressed satisfaction that their chosen program aligns with their career path and that the course format fits into their busy lives.

To support students managing these competing demands, University of Phoenix offers resources including flexible course scheduling, on-demand support and access to its Life Resource Center.

About University of Phoenix

University of Phoenix is Built for Real Life. 50 Years Strong. The University innovates to help working adults enhance their careers and develop skills in a rapidly changing world through flexible online learning, relevant courses, academic AI pillars, and skills-mapped curriculum for associate, bachelor’s and master’s degree programs. Active students and alumni have access to Career Services for Life® resources including career guidance and tools. For more information, visit phoenix.edu.

View original content to download multimedia:https://www.prnewswire.com/news-releases/university-of-phoenix-highlights-student-success-stories-from-presidents-and-deans-list-honorees-302874381.html

SOURCE University of Phoenix

Continue Reading

Technology

iFlex Stretch Studios Adds Kinotek® 3D Movement Technology to Every Experience

Published

on

By

The assisted stretching franchise combines markerless, AI-driven movement analysis with certified stretch therapist expertise to deliver more personalized programming and enhanced member experiences.

NEWPORT BEACH, Calif., Sept. 9, 2026 /PRNewswire/ — iFlex Stretch Studios, the assisted stretching and mobility brand under Sequel Brands, today announced the addition of Kinotek®’s 3D movement assessment technology across its studio network. The integration provides iFlex stretch therapists with a precise, visual understanding of each client’s mobility, potential asymmetries, and movement patterns to further personalize their stretching experience.

Before a therapist begins a session, Kinotek’s markerless 3D movement assessment captures a client’s body in motion – no markers, sensors, or wearables required. In seconds, the technology analyzes range of motion, symmetry, and movement quality to provide deeper insights into each client’s mobility needs.

Each initial assessment helps establish a personalized stretching plan, with movement data informing AI-supported programming that therapists use to customize sessions, recommend at-home mobility work, and suggest recovery and mobility products aligned with individual goals.

“Assisted stretching has always come down to what a good stretch therapist can see and feel,” said Verdine Baker, Founder of iFlex Stretch Studios. “Kinotek gives our therapists a second set of eyes. It shows them things the human eye may miss and gives clients a clear way to see their progress session over session.”

The rollout follows a period of steady growth for iFlex, which has expanded across Arizona, Texas, Florida, California, Georgia, New Mexico, and Virginia under Sequel Brands while continuing to add franchise territories nationwide. Adding Kinotek across the network builds on the brand’s commitment to a more technology-driven studio experience, following the introduction of AI-supported client communication tools earlier this year.

“Movement health is one of the clearest predictors of how well and how independently people live as they age, and until recently there was no fast, practical way to measure it,” said Dr. Marty Miller, Chief Movement Officer at Kinotek. “iFlex is putting an objective measurement in front of every client and pairing it with therapists trained to act on it. Data plus skilled hands is what actually changes outcomes.”

For clients, Kinotek establishes a baseline at the first visit and enables progress tracking over time through easy-to-understand scored movement reports. The technology transforms mobility improvements into measurable insights, helping clients visualize progress beyond simply feeling better.

The technology is now available at participating iFlex locations, with additional studios rolling out Kinotek in the coming months.

To learn more about iFlex Stretch Studios, book a session, or inquire about franchise ownership, visit www.iflexstretchstudios.com or follow @iFlexStretchStudios on social media.

About iFlex Stretch Studios

iFlex Stretch Studios is a Sequel Brands company and a premier assisted stretching franchise offering personalized, therapist-led sessions designed to improve mobility, flexibility, and overall wellness. Founded in 2022 and acquired by Sequel Brands in 2025, iFlex has expanded from its first Arizona studio to locations across Texas, Florida, California, Georgia, New Mexico, and Virginia under the leadership of CEO Verdine Baker. Each guest begins with a personalized flexibility assessment, with ongoing progress tracking to support customized programming. iFlex is actively expanding franchise opportunities nationwide.

About Kinotek

Kinotek is a movement health company serving fitness, wellness, and medical professionals. Its markerless 3D platform measures a client’s movement in seconds, giving trainers, therapists, and clinicians an objective read on movement health – a leading indicator of longevity – and a way to track progress over time. For more information go to www.kinotek.com.

Media Contact:
Sequel Brands Communications
communications@sequelbrands.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/iflex-stretch-studios-adds-kinotek-3d-movement-technology-to-every-experience-302874396.html

SOURCE iFlex Stretch Studios

Continue Reading

Technology

BioEdge Research Labs Advances Transparency in Research Compound Documentation

Published

on

By

US-based research peptide supplier expands access to batch-level analytical documentation for its research-use-only materials, so researchers can verify identity and purity records for the lot they receive. All products are sold for laboratory research use only.

MIAMI, Sept. 9, 2026 /PRNewswire/ — BioEdge Research Labs, a United States-based supplier of research peptides and reference materials, today announced an initiative to advance transparency in how its research materials are documented. The initiative expands researcher access to batch-level analytical records for the company’s research-use-only materials.

Transparency has become a distinguishing factor in the research materials market. Because documentation practices vary from supplier to supplier, laboratory and research customers increasingly look for records they can review and confirm, rather than relying on a supplier’s summary alone. BioEdge’s initiative centers on making batch-level analytical documentation accessible for the material a researcher actually receives.

Accessible Certificates of Analysis

Each lot supplied by BioEdge is paired with its own Certificate of Analysis (COA), and batch-specific COAs are made available on the company’s product pages. Rather than a single certificate carried across multiple production runs, each vial carries a lot number that corresponds to the documentation for that batch, so the record can be matched to the material in hand.

Independent Analysis Behind the Record

The documentation reflects analysis performed by an independent third-party laboratory, covering identity by mass spectrometry (MS), purity by high-performance liquid chromatography (HPLC), and contaminant screening. Because the underlying analysis is conducted by a separate laboratory, the record reflects more than a supplier’s own description of the material.

Records a Researcher Can Match

The emphasis on batch-level records is intended to let a researcher confirm that a document corresponds to the specific lot received. Matching the lot number on the vial to its Certificate of Analysis is a straightforward check, and one that BioEdge’s documentation practices are designed to support across the product line.

Research Use Only

All materials supplied by BioEdge Research Labs are sold strictly for laboratory research and in vitro use by qualified researchers and scientific professionals. They are not drugs, supplements, or medical products.

About BioEdge Research Labs

BioEdge Research Labs is a United States-based supplier of research peptides and reference materials serving laboratory and research customers. The company sources from reputable U.S.-based facilities and supports its research-grade materials with independent third-party analytical testing and batch-specific Certificates of Analysis. Learn more at https://bioedgeresearchlabs.com

Media Contact

BioEdge Research Labs
2751 Biscayne Harbor Drive, Suite 620
Miami, FL 33137
(305) 757-0163
admin@thebioedgeresearchlabs.com

All products sold by BioEdge Research Labs are intended strictly for laboratory research and in vitro use by qualified researchers and scientific professionals. These products are not intended to diagnose, treat, cure, or prevent any disease, are not intended to affect the structure or any function of the body, and are not intended for human or veterinary use, consumption, or self-administration. They have not been evaluated or approved by the U.S. Food and Drug Administration for diagnostic, therapeutic, or preventative purposes. BioEdge Research Labs is a chemical supplier and is not a compounding pharmacy or outsourcing facility as defined under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act. BioEdge Research Labs makes no therapeutic claims.

View original content:https://www.prnewswire.com/news-releases/bioedge-research-labs-advances-transparency-in-research-compound-documentation-302874401.html

SOURCE BioEdge Research Labs

Continue Reading

Trending